MUMBAI, India, June 30 -- Intellectual Property India has published a patent application (202641054440 A) filed by Saveetha Institute Of Medical And Technical Sciences on April 29, 2026, for Insulin Dosage Monitoring And Prediction.
Inventors include Mr Dharmapuri Ram Prasad; Dr. Senthll Kumar; and Dr Ramya Mohan.
The application for the patent was published on June 26, 2026, under issue no. 26/2026.
Abstract: INSULIN DOSAGE MONITORING AND PREDICTION ABSTRACT The present invention relates to a health monitoring and insulin management system designed to improve the safety, accuracy, and confidence of diabetic patients in managing their insulin therapy. Specifically, it discloses a mobile-based platform titled "Insulin Dosage Monitoring & Prediction" which otTers AT-powered, personalized insulin dosage recommendations and instructional support for-insulin ·a-dministratio-n~ The system integrates reat=ti1ne data--from ghlcose monitors, weanil5le fitness devices, and user inputs (such as meal intake, activity level, and body weight) to calculate the required insulin dosage. It comprises two main interfaces: a patient interface for daily usage and a doctor interface for remote monitoring and consultation. The system ensures better compliance, reduced dosage errors, and improved user education through a simplified, voice-guided interface suitable for elderly patients and first-time insulin users. It promotes proactive diabetes care and reduces long-term complications through predicti.Ye analyti~and secure communication channels
Disclaimer: Curated by HT Syndication.
